CORVUS PHARMACEUTICALS INC

$CRVS
Smart money positioned

11 of the Top-200 alpha managers hold $CRVS as of the latest 13F snapshot.

13F holders
158
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

11 holders · Q1 2026

$CRVS is held by 11 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.89%, with an average of 0.12% of portfolio. Largest holder: Diadema Partners LP at 0.89%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 158 · Source: 13F-HR
01
Sculptor Capital LP
2.09% of portfolio
7,165,006 sh
02
Point72 Asset Management, L.P.
0.09% of portfolio
6,454,274 sh
03
Axa S.a.
3,565,992 sh
04
Texas Treasury Safekeeping Trust Co.
18.41% of portfolio
3,275,616 sh
05
Vivo Capital, LLC
3.41% of portfolio
2,805,816 sh
06
Mint Tower Capital Management B.V.
3.43% of portfolio
2,805,816 sh
07
State Street
2,788,223 sh
08
RWQ Financial Management Services, Inc.
0.60% of portfolio
2,491,539 sh
09
Vernal Point Advisors, LLC
1.91% of portfolio
2,258,735 sh
10
Bey-Douglas LLC
5.82% of portfolio
1,831,233 sh
See all 158 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $CRVS in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $CRVS in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 09:58 UTC.